
Patient‐Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019
Author(s) -
Bhatnagar Vishal,
Hudgens Stacie,
PiaultLouis Elisabeth,
Jones Lee,
Beaver Julia A.,
Lyerly H. Kim,
Reaman Gregory,
Fleming Thomas,
Kluetz Paul G.
Publication year - 2020
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2020-0062
Subject(s) - medicine , clinical trial , precision oncology , medical physics , session (web analytics) , oncology , clinical oncology , cancer , intensive care medicine , world wide web , computer science
The measurement and analysis of patient‐reported outcomes is important in cancer clinical trials. This commentary reports advances and challenges from presentations at the 2019 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop Patient‐Reported Outcomes Session.